Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm ...

In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Avita Medical (RCEL – Research Report), with a ...

Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

In a report released on January 5, Deepak Mathivanan from Cantor Fitzgerald maintained a Buy rating on Amazon (AMZN – Research Report), with a ...

Cantor Fitzgerald began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm issued an overweight ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares are ...

(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

On Tuesday, Vincerx Pharma Inc (VINC) stock saw a modest uptick, ending the day at $0.21 which represents no change from the prior close of of $0.21. The stock opened at $0.21 and touched a low of ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...